子宫内膜癌的临床诊治进展

于小雨，马利国

（1 .暨南大学第二临床医学院，广东 深圳，518020 ；2 .深圳市人民医院，广东 深圳，518020）

浏览次数：146次 下载次数：366次

摘要：

子宫内膜癌（endometrial carcinoma, EC）是女性生殖系统的三大恶性肿瘤之一，其发病率逐年上升。EC的发病机制尚不十分明确，可能与基因突变有关。目前认为，宫腔镜下分段诊刮是可靠的诊断EC的手段，经阴道彩超是较好的筛查方法，磁共振成像（magnetic resonance imaging, MRI）是术前评估盆腹腔病灶最准确的检查。EC的治疗应当个体化，以手术治疗为主，根据手术病理辅以放疗、化疗或内分泌治疗。本文主要就该病的病因、诊断及治疗方面的国内外研究进展进行总 结论述。

关键词：子宫内膜癌；宫腔镜；磁共振成像

中图分类号：R737.33文献标志码：A文章编号：2096-1413(2017)11-0190-04

Advances in clinical diagnosis and treatment of endometrial carcinoma
YU Xiao-yu 1,2, MA Li-guo 1,2
(1. the Second Clinical Medical College of Jinan University, Shenzhen 518020; 2. Shenzhen People's Hospital,
Shenzhen 518020, China)

ABSTRACT: Endometrial carcinoma (EC) is one of the three most common malignancies of the female reproductive system. The number of diagnosed cases of EC is rising every year. Its etiology remains unclear and might relate to gene mutation. Hysteroscopy assisted segment curettage is considered to be a reliable method in the diagnosis of EC. Transvaginal color doppler ultrasound is believed to be a effective screening technique for EC. It is accepted that MRI is an accurate examination method for preoperative evaluation of pelvic or abdominal lesions. The treatment of EC should be individualized and mainly based on surgical treatment and supplemented by radiotherapy, chemotherapy and endocrine therapy when necessary. This paper summarizes the research progress of etiology, diagnosis and treatment of EC.
KEYWORDS: endometrial carcinoma; hysteroscopy; magnetic resonance imaging

参考文献：
[1] TORRE LA,BRAY F,SIEGEL RL,et al.Global Cancer Statistic,2012 [J].Ca A Cancer J Clin,2015,65(2):87-108.
[2] TRABERT B,WENTZENSEN N,FELIX AS,et al.Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database[J].Cancer Epidemiol Biomarkers Prev, 2015,24(1):261-267.
[3] 全国肿瘤防治研究办公室.中国肿瘤登记年报.2004[M].北京:中国协和医科大学出版社,2008.
[4] 赫捷,赵平,陈万青.2011 中国肿瘤登记年报[M]北京:军事医学出版社,2012.
[5] LIU P,QI M,MA C,et al.Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B[J].FEBS Lett,2013,587(16):2523-2529.
[6] PENG WX,KUDO M,FUJII T,et al.Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation[J].Inter J Clin Exp Pathol,2014,7(3):1069-1076.
[7] BLUMENTHAL GM,DENNIS PA.Germline PTEN mutations as a cause of early-onset endometrial cancer[J].J Clin Oncol,2008,26(13): 2234.
[8] LAGARDA H,CATASUS L,ARGUELLES R,et al.K-ras mutations in endometrial carcinomas with microsatellite instability [J].J Pathol,2001, 193(2):193-199.
[9] PURDIE DM,GREEN AC.Epidemiology of endometrial cancer[J].Best Pract Res Clin Obstet Gynaecol,2001,15(3):341-354.
[10] KEY TJ,PIKE MC.The dose -effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk[J].Br J Cancer,1988,57 (2):205-212.
[11] KAAKS R,LUKANOVA A,KURZER MS,et al.Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review [J].Cancer Epidemiol Biomarkers Prev,2003,11(12):1531-1543.
[12] 谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:313-316.
[13] STOLER M,BERGERON C,COLGAN TJ,et al.WHO classification of tumours of female reproductive organs[M].Lyon: International Agency for Research on Cancer,2014:169-189.
[14] BAAK JPA,MUTTER GL.EIN and WHO94[J].J Clin Pathol,2005,58 (1):1-6.
[15] CHANG YN,ZHANG Y,WANG YJ,et al.Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a Meta-analysis[J].Fertil Steril,2011,96(4):957-961.
[16] TIMMERMANS A,OPMEER BC,KHAN KS,et al.Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and Meta-analysis[J].Obstet Gynecol,2010,116(1):160.
[17] 彭丽珊,梁文通,陈达丽,等.经阴道超声对绝经后子宫内膜病变的诊断价值[J].中华超声影像学杂志,2004,13(10):797-798.
[18] OZDEMIR S,CELIK C,EMLIK D,et al.Assessment of myometrial invasion in endometrial cancer by transvaginal sonography, Doppler ultrasonography, magnetic resonance imaging and frozen section [J].Inter J Gynecol Cancer,2009,19(6):1085-1090.
[19] 孙晓伟,朱颖,王霄英,等.EC盆腔淋巴结转移的不同MR序列诊断研究[J].中国医学影像学杂志,2011,19(5):394-398.
[20] BIE Y,ZHANG Z.Diagnostic value of serum HE4 in endometrial cancer: a Meta-analysis[J].World J Surg Oncol,2014,12(1):1-6.
[21] BRENNAN DJ,HACKETHAL A,METCALF AM,et al.Serum HE4 as a prognostic marker in endometrial cancer-A population based study [J].Gynecol Oncol,2014,132(1):159-165.
[22] BRENNAN DJ,HACKETHAL A,MANN KP,et al.Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance[J].BMC Cancer,2015,15(1):1-9.
[23] KEMIK P,SAATLI B.Diagnostic and prognostic values of preoperative serum levels of YKL-40,HE-4 and DKK-3 in endometrial cancer [J].Gynecol Oncol,2016,140(1):64-69.
[24] PALOMBA S,FALBO A,MOCCIARO R,et al.Laparoscopic treatment for endometrial cancer: a Meta-analysis of randomized controlled trials (RCTs)[J].Gynecol Oncol,2009,112(2):415-421.
[25] EKLIND S,LINDFORS A.A prospective, comparative study on robotic versus open-surgery hysterectomy and pelvic lymphadenectomyfor endometrial carcinoma[J].Int J Gynecol Cancer,2015,25(2):250-256. [26] ANGIOLI R,PLOTTI F,CAFA EV,et al.Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy[J].Eur J Obstet Gynecol Reprod Biol,2013,170(2):539-543.
[27] CHAN JK,WU H,CHEUNG MK,et al.The outcomes of 27 063 women with unstaged endometrioid uterine cancer [J].Gynecol Oncol, 2007,106(2):282-288.
[28] EGGEMANN H,IGNATOV T,KAISER K,et al.Survival advantage of lymphadenectomy in endometrial cancer [J].J Cancer Res Clin Oncol, 2016,142(5):583-602.
[29] WRIGHT JD,HUANG Y,BURKE WM,et al.Influence of lymphadenectomy on survival for early -stage endometrial cancer [J].Obstet Gynecol,2015,127(1):109.
[30] UCCELLA S,PODRATZ KC,ALETTI GD,et al.Re: systematic pelvic lymphadenectomy vs. no lymphadenectomy in early -stage endometrial carcinoma: randomized clinical trial[J].J Natl Cancer Inst,2009,101(12): 898-899.
[31] TODO Y,KATO H,KANEUCHI M,et al.Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis[J].Lancet,2010,375(9721):1165-1172.
[32] CREUTZBERG CL,NOUT RA,LYBEERT MLM,et al.Fifteen -year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma[J].Int J Radiat Oncol Biol Phys,2011,81(4):631-638.
[33] KONG A,JOHNSON N,KITCHENER HC,et al.Adjuvant radiotherapy for stage I endometrial cancer[M].John Wiley & Sons,Ltd,2012.
[34] NOUT RA,SMIT VT,PUTTER H,et al.Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial[J].Lancet,2010,375(9717):5552-5561.
[35] SORBE BG,HORVATH G,ANDERSSON H,et al.External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study --quality-of -life analysis [J].Int J Radiat Oncol Biol Phys, 2011,82(3):1249-1255.
[36] SUSUMU N,SAGAE S,UDAGAWA Y,et al.Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate and high -risk endometrial cancer: a Japanese gynecologic oncology group study[J].Gynecol Oncol,2008,108 (1):226-233.
[37] MAGGI R,LISSONI A,SPINA F,et al.Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial[J].Br J Cancer,2006,95(3):266-271.
[38] 王志启,王建六,郭健,等.内分泌辅助治疗子宫内膜癌的临床意义 [J].中华医学杂志,2005,85(34):2414-2419.
[39] ITO K,UTSUNOMIYA H,YAEGASHI N,et al.Biological roles of estrogen and progesterone in human endometrial carcinoma--new develop ments in potential endocrine therapy for endometrial cancer[J].Endocr J, 2007,54(5):667-679.
[40] SLOMOVITZ BM,JIANG Y,YATES MS,et al.Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma[J].J Clin Oncol,2015,33(8):930-936.
[41] MADEDDU C,GRAMIGNANO G,KOTSONIS P,et al.Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: a report of two cases[J].Oncol lett,2014,8(3):1279-1282.